|
1
|
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
|
N Engl J Med
|
2006
|
7.42
|
|
2
|
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
|
Blood
|
2007
|
5.18
|
|
3
|
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
|
Blood
|
2013
|
3.03
|
|
4
|
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
|
J Exp Med
|
2009
|
2.80
|
|
5
|
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.
|
J Clin Oncol
|
2007
|
2.35
|
|
6
|
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
|
Nat Genet
|
2012
|
2.07
|
|
7
|
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
|
Proc Natl Acad Sci U S A
|
2013
|
2.00
|
|
8
|
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
|
Blood
|
2008
|
1.97
|
|
9
|
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
|
Br J Haematol
|
2005
|
1.96
|
|
10
|
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
|
Blood
|
2009
|
1.84
|
|
11
|
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
|
Blood
|
2012
|
1.82
|
|
12
|
Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
|
Haematologica
|
2008
|
1.80
|
|
13
|
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
|
Blood
|
2012
|
1.79
|
|
14
|
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
|
J Clin Oncol
|
2010
|
1.79
|
|
15
|
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.
|
J Exp Med
|
2008
|
1.74
|
|
16
|
Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
|
Histopathology
|
2013
|
1.71
|
|
17
|
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
|
Blood
|
2013
|
1.71
|
|
18
|
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
|
Br J Haematol
|
2008
|
1.60
|
|
19
|
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.
|
Blood
|
2011
|
1.51
|
|
20
|
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.
|
PLoS One
|
2009
|
1.48
|
|
21
|
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
|
Blood
|
2007
|
1.46
|
|
22
|
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.
|
Blood
|
2006
|
1.45
|
|
23
|
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.
|
Blood
|
2008
|
1.42
|
|
24
|
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
|
Blood
|
2011
|
1.39
|
|
25
|
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.
|
Blood
|
2007
|
1.35
|
|
26
|
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.
|
Blood
|
2010
|
1.33
|
|
27
|
The RNA subunit of telomerase is encoded by Marek's disease virus.
|
J Virol
|
2003
|
1.32
|
|
28
|
Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells.
|
Gastroenterology
|
2005
|
1.26
|
|
29
|
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.
|
Haematologica
|
2007
|
1.25
|
|
30
|
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
|
Blood
|
2003
|
1.25
|
|
31
|
A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.
|
Blood
|
2006
|
1.25
|
|
32
|
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
|
J Clin Oncol
|
2010
|
1.21
|
|
33
|
PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.
|
Oncogene
|
2003
|
1.21
|
|
34
|
Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials.
|
Haematologica
|
2009
|
1.20
|
|
35
|
Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.
|
J Clin Oncol
|
2011
|
1.16
|
|
36
|
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
|
Haematologica
|
2008
|
1.15
|
|
37
|
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.
|
Blood
|
2012
|
1.14
|
|
38
|
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
|
Blood
|
2010
|
1.11
|
|
39
|
Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
|
J Clin Oncol
|
2014
|
1.10
|
|
40
|
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.
|
J Hematop
|
2009
|
1.07
|
|
41
|
Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.
|
Br J Haematol
|
2008
|
1.07
|
|
42
|
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
|
Leuk Lymphoma
|
2012
|
1.07
|
|
43
|
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status.
|
Genes Chromosomes Cancer
|
2009
|
1.06
|
|
44
|
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
|
Haematologica
|
2013
|
1.05
|
|
45
|
Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
|
J Clin Oncol
|
2008
|
1.05
|
|
46
|
Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.
|
Blood
|
2013
|
1.03
|
|
47
|
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
|
J Clin Oncol
|
2007
|
1.03
|
|
48
|
Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
|
Br J Haematol
|
2009
|
1.02
|
|
49
|
Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
|
J Pathol
|
2005
|
1.01
|
|
50
|
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
|
J Clin Oncol
|
2011
|
1.00
|
|
51
|
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
|
Haematologica
|
2008
|
1.00
|
|
52
|
In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.
|
Blood
|
2009
|
0.99
|
|
53
|
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
|
Genes Chromosomes Cancer
|
2014
|
0.99
|
|
54
|
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
|
Haematologica
|
2012
|
0.99
|
|
55
|
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
|
Blood
|
2014
|
0.98
|
|
56
|
Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens.
|
Blood
|
2013
|
0.96
|
|
57
|
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
|
Haematologica
|
2010
|
0.96
|
|
58
|
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
|
Cancer Res
|
2006
|
0.96
|
|
59
|
Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells.
|
Am J Surg Pathol
|
2007
|
0.96
|
|
60
|
Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12.
|
Neurobiol Dis
|
2002
|
0.95
|
|
61
|
Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.
|
Br J Haematol
|
2007
|
0.95
|
|
62
|
Clonality in juvenile xanthogranuloma.
|
Am J Surg Pathol
|
2007
|
0.94
|
|
63
|
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
|
J Neuropathol Exp Neurol
|
2008
|
0.93
|
|
64
|
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
|
PLoS One
|
2011
|
0.93
|
|
65
|
Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
|
Br J Haematol
|
2012
|
0.93
|
|
66
|
Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.
|
Haematologica
|
2010
|
0.93
|
|
67
|
Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
|
Haematologica
|
2013
|
0.93
|
|
68
|
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.
|
Haematologica
|
2009
|
0.93
|
|
69
|
Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.
|
Am J Pathol
|
2004
|
0.92
|
|
70
|
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma.
|
Leuk Res
|
2009
|
0.92
|
|
71
|
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel.
|
Am J Surg Pathol
|
2011
|
0.91
|
|
72
|
Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma.
|
Blood
|
2006
|
0.91
|
|
73
|
Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination.
|
J Neuropathol Exp Neurol
|
2006
|
0.90
|
|
74
|
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.
|
Genes Chromosomes Cancer
|
2012
|
0.90
|
|
75
|
The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.
|
Hum Pathol
|
2012
|
0.90
|
|
76
|
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
|
Br J Haematol
|
2008
|
0.90
|
|
77
|
Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
|
Leuk Lymphoma
|
2008
|
0.89
|
|
78
|
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
|
Haematologica
|
2009
|
0.88
|
|
79
|
Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
|
Exp Mol Pathol
|
2012
|
0.87
|
|
80
|
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
|
Acta Neuropathol
|
2013
|
0.87
|
|
81
|
Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma.
|
Blood
|
2014
|
0.87
|
|
82
|
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
|
Blood
|
2013
|
0.86
|
|
83
|
The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma.
|
Int J Cancer
|
2007
|
0.86
|
|
84
|
Cutaneous and systemic plasmocytosis.
|
J Dtsch Dermatol Ges
|
2013
|
0.86
|
|
85
|
Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma.
|
Am J Pathol
|
2013
|
0.84
|
|
86
|
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
|
Haematologica
|
2010
|
0.84
|
|
87
|
Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma.
|
Br J Haematol
|
2014
|
0.84
|
|
88
|
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
|
Histopathology
|
2011
|
0.84
|
|
89
|
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
|
Blood
|
2010
|
0.84
|
|
90
|
Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia.
|
Sci Transl Med
|
2013
|
0.83
|
|
91
|
Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays?
|
Histopathology
|
2011
|
0.83
|
|
92
|
Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
|
Hum Pathol
|
2013
|
0.83
|
|
93
|
Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma.
|
Haematologica
|
2008
|
0.82
|
|
94
|
Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
|
Transplantation
|
2012
|
0.81
|
|
95
|
Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.
|
Haematologica
|
2011
|
0.81
|
|
96
|
Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphoma.
|
Haematologica
|
2009
|
0.81
|
|
97
|
High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
|
Genes Chromosomes Cancer
|
2012
|
0.81
|
|
98
|
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
|
Br J Haematol
|
2014
|
0.80
|
|
99
|
BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
|
Cancer Genet Cytogenet
|
2008
|
0.80
|
|
100
|
ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and down-regulated in classical Hodgkin's lymphoma.
|
Haematologica
|
2012
|
0.80
|
|
101
|
An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2010
|
0.79
|
|
102
|
Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule.
|
Cancer Med
|
2014
|
0.79
|
|
103
|
Germline variations of the MALT1 gene as risk factors in the development of primary gastric B-cell lymphoma.
|
Eur J Cancer
|
2009
|
0.79
|
|
104
|
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive.
|
Histopathology
|
2011
|
0.79
|
|
105
|
Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas.
|
PLoS One
|
2013
|
0.77
|
|
106
|
Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
|
Haematologica
|
2013
|
0.77
|
|
107
|
Regulation of repp86 stability by human Siah2.
|
Biochem Biophys Res Commun
|
2007
|
0.77
|
|
108
|
The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage.
|
Histopathology
|
2009
|
0.77
|
|
109
|
Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
|
Virchows Arch
|
2014
|
0.76
|
|
110
|
Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
|
Int J Cancer
|
2014
|
0.76
|
|
111
|
Absence of BRAF mutation in pediatric and adolescent germ cell tumors indicate biological differences to adult tumors.
|
Pediatr Blood Cancer
|
2011
|
0.76
|
|
112
|
EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease.
|
Transplantation
|
2013
|
0.75
|
|
113
|
Endogenous interferon α therapy in follicular lymphoma?
|
Leuk Lymphoma
|
2011
|
0.75
|
|
114
|
Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia.
|
Oral Maxillofac Surg
|
2008
|
0.75
|
|
115
|
Expression and pro-survival function of phospholipase Cγ2 in diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
116
|
Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
|
Eur J Haematol
|
2014
|
0.75
|
|
117
|
Gingival ulceration and exposed bone.
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
0.75
|
|
118
|
Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
|
Histopathology
|
2013
|
0.75
|
|
119
|
Follicular lymphoma: still Six characters in search of an author?
|
Leuk Lymphoma
|
2011
|
0.75
|
|
120
|
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
|
Br J Haematol
|
2007
|
0.75
|
|
121
|
No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
122
|
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
|
Int J Cancer
|
2013
|
0.75
|
|
123
|
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment: case report and review of the literature.
|
Strahlenther Onkol
|
2014
|
0.75
|
|
124
|
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
|
Am J Surg Pathol
|
2015
|
0.75
|
|
125
|
Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.
|
Br J Haematol
|
2014
|
0.75
|